Keros Therapeutics, Inc. (KROS) Earnings
NASDAQ·Healthcare·Biotechnology
$11.50
+1.46%
Mkt Cap $230.39M
EPS — Estimate vs Actual
Mkt Cap
$230.39M
P/E
4.44
Fwd P/E
4.76
P/S
6.94
Rev TTM
—
EPS TTM
-$1.95
NASDAQ·Healthcare·Biotechnology
$11.50
+1.46%
Mkt Cap $230.39M
Mkt Cap
$230.39M
P/E
4.44
Fwd P/E
4.76
P/S
6.94
Rev TTM
—
EPS TTM
-$1.95